Table 1.
NO. | Gender | Age | Pathology | Diagnosis time (eye after CNS) | Laterality | Initial VA | Latest VA |
---|---|---|---|---|---|---|---|
1 | M | 56 | DLBCL | 1 month | L | 0.1 | 0.9 |
2 | F | 68 | DLBCL | 2 months | R | 0.8 | 0.6 |
L | 0.8 | 0.8 | |||||
3 | M | 58 | DLBCL | 5 months | R | 0.5 | 0.8 |
1 month | L | 0.5 | 1.0 | ||||
4 | M | 72 | DLBCL | 6 months | R | 0.15 | 0.6 |
L | 0.4 | 0.8 | |||||
5 | F | 54 | DLBCL | 14 months | L | 0.25 | 0.5 |
6 | M | 65 | DLBCL | 4 months | R | HM\BE | 0.01 |
L | 0.15 | FC/20 cm | |||||
7 | F | 45 | DLBCL | 23 months | R | 0.2 | 0.8 |
L | 0.4 | 0.7 | |||||
8 | M | 67 | DLBCL | Concurrent | R | FC/20 cm | 0.6 |
9 | F | 71 | DLBCL | Concurrent | L | FC/20 cm | 0.1 |
10 | F | 54 | DLBCL | Concurrent | R | 1.0 | 0.7 |
L | 0.6 | 0.6 | |||||
11 | M | 56 | DLBCL | 32 months | R | 0.4 | 0.8 |
12 | M | 51 | DLBCL | Concurrent | L | FC/20 cm | 0.5 |
13 | M | 59 | DLBCL | 5 months | R | 0.15 | 1.0 |
L | 0.5 | 1.0 | |||||
14 | M | 73 | DLBCL | 54 months | R | 0.25 | 1.0 |
15 | M | 72 | T cell lymphoma | 2 months | R | 0.6 | 0.8 |
L | 0.6 | 0.8 | |||||
16 | F | 42 | DLBCL | Concurrent | R | 1.0 | 1.0 |
17 | M | 53 | DLBCL | Concurrent | L | 0.6 | 0.6 |
18 | F | 55 | DLBCL | Concurrent | R | 0.5 | 0.6 |
L | 0.5 | 0.8 | |||||
19 | F | 65 | DLBCL | Concurrent | R | 0.3 | 0.7 |
L | 0.3 | 0.7 | |||||
20 | F | 61 | DLBCL | Concurrent | R | 0.4 | 0.9 |
21 | F | 65 | DLBCL | 3 months | L | 0.1 | – |
22 | M | 53 | DLBCL | 22 months | R | 0.8 | – |
L | 0.8 | – |
VA Visual acuity, M Male, F Female, R Right, L Left, DLBCL = diffuse large B-cell lymphoma, CNS Central nervous system, HM/BE Hand movement before eye, FC Finger count